Literature DB >> 11075834

Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients.

J E Palmer1, E P Chronicle, P Rolan, W M Mulleners.   

Abstract

Recent studies of the visual cortex in patients with migraine have generally concluded that migraine (particularly migraine with aura) is associated with a state of functional cortical hyperexcitability. The mechanisms giving rise to this hyperexcitability have hitherto been unclear. This paper reports two studies that used a novel investigative technique, derived from basic research in vision science, to examine specific deficits of inhibitory processing in primary visual cortex. The technique is termed the metacontrast test, and it examines visual masking under highly specified conditions. In Study 1, 12 migraine with aura patients (MA), 12 age-matched migraine without aura patients (MO) and 12 age- and sex-matched headache-free control subjects (C) were compared using the metacontrast test. MA patients were significantly less susceptible to visual masking in the metacontrast test than both MO and C groups: this result is highly consistent with a deficit in cortical inhibitory processing in MA patients. Study 2 examined MA patients taking a variety of migraine prophylactics, again using the metacontrast test. Test results normalized in those MA patients taking sodium valproate, but not in those taking other prophylactics. Sodium valproate is a GABA-A agonist that is known to cross the blood-brain barrier: GABA-ergic networks act as the primary inhibitory mechanism in visual cortex. Taken together, the results of these studies argue that cortical hyperexcitability, at least in MA patients, is likely to be a result of deficient intracortical inhibitory processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11075834     DOI: 10.1046/j.1468-2982.2000.00075.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  24 in total

1.  Does habituation depend on cortical inhibition? Results of an rTMS study in healthy subjects.

Authors:  A Palermo; G Giglia; S Vigneri; G Cosentino; B Fierro; F Brighina
Journal:  Exp Brain Res       Date:  2011-05-03       Impact factor: 1.972

Review 2.  Cellular mechanisms underlying the pharmacological induction of phosphenes.

Authors:  L Cervetto; G C Demontis; C Gargini
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

3.  An inability to exclude visual noise in migraine.

Authors:  Marc S Tibber; Maria G Kelly; Ashok Jansari; Steven C Dakin; Alex J Shepherd
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

4.  TNF-α and Microglial Hormetic Involvement in Neurological Health & Migraine.

Authors:  Richard P Kraig; Heidi M Mitchell; Barbara Christie-Pope; Phillip E Kunkler; David M White; Ya-Ping Tang; George Langan
Journal:  Dose Response       Date:  2010-02-18       Impact factor: 2.658

5.  Epilepsy and medication effects on the pattern visual evoked potential.

Authors:  Andrew M Geller; H Ken Hudnell; Bradley V Vaughn; John A Messenheimer; William K Boyes
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

6.  Antiepileptic Drug Therapy in Migraine Headache.

Authors:  Steve D. Wheeler
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

7.  Facilitatory effects of 1 Hz rTMS in motor cortex of patients affected by migraine with aura.

Authors:  Filippo Brighina; Giuseppe Giglia; Simona Scalia; Margherita Francolini; Antonio Palermo; Brigida Fierro
Journal:  Exp Brain Res       Date:  2004-10-12       Impact factor: 1.972

Review 8.  Perceptive aspects of visual aura.

Authors:  Carlo Aleci; William Liboni
Journal:  Neurol Sci       Date:  2009-09-25       Impact factor: 3.307

9.  Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain.

Authors:  N Hanoun; F Saurini; L Lanfumey; M Hamon; S Bourgoin
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 10.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.